Zhen Zhao

Jan 15, 2025 | mdpi.com | Yuanke Li |Ruiying Liu |Zhen Zhao

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Jan 8, 2025 | pubs.rsc.org | Yuwei Dong |Mingyu Wu |Yu Ren |Zhen Zhao

Big pyridyl Schiff base π-conjugated skeleton based cobalt/iron metal complexes: a bimetallic electrocatalyst for oxygen evolution reaction Schiff base metal complexes exhibit huge potential as efficient electrocatalysts for oxygen evolution reaction (OER). However, the high overpotential and complex synthesis process largely restrict their practical application.

Nov 11, 2024 | biorxiv.org | Zhen Zhao |Haowen Qiao |Yafei Qu |Lingxi Qiu

AbstractThe coronavirus disease of 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), remains a major health issue after nearly 7 millions of death toll in the last four years. As the world is recovering with improving vaccines and antiviral treatments, the alarming rate of long-COVID, or Post-acute Sequelae of COVID-19 (PASC), calls for further investigations.

Oct 24, 2024 | mdpi.com | Shaokang Yang |Zhen Zhao |Shengbin Wang |Shanhu Xiao

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Oct 19, 2024 | dx.doi.org | Weifei Zhang |Mengqing Li |Zhen Zhao |Jiangshan Xu

1. IntroductionClick to copy section linkSection link copied!Osteosarcoma, a malignant tumor common in teenagers, has an incidence rate of approximately three per million. (1) Its five year survival rate is approximately 20% and lacks treatment options. (2) The survival rate for osteosarcoma patients has not improved over the past 30 years, (3) highlighting the urgent need for novel therapeutic strategies.